Tag: CNMC
PAF welcomes the news that the Spanish competition authority has fined Leadiant €10,25 million
Farma ter Verantwoording -
AMSTERDAM: The Pharmaceutical Accountability Foundation (PAF), a group of legal and medical experts and public health advocates, today welcomes the news that the Spanish competition authority CNMC has fined pharmaceutical company Leadiant €10.25 million for its abuse of its market position to overcharge sufferers of a rare genetic disease.
Apart...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022